Influence of physicians' risk perception on switching treatments between high- efficacy and non-high-efficacy disease‑modifying therapies in multiple sclerosis
Abstract
The decision of initiating treatment for multiple sclerosis (MS) with a high-efficacy DMT (HE DMT) or non-high-efficacy DMT (non-HE DMT) is influenced by several factors, including risk perception of patients and physicians.
Citations
Altmetric:
Date
2023-05-26
Type
Article
Subject
Diseases & disorders of the nervous system (e.g. Parkinson's), Neurology
Collections
Citation
Mult Scler Relat Disord . 2023 Aug;76:104770
Journal / Source Title
Multiple Sclerosis and Related Disorders
DOI
10.1016/j.msard.2023.104770
PMID
37307690
Publisher
Elsevier
Publisher’s URL
https://www.msard-journal.com/article/S2211-0348(23)00272-9/fulltext